UA27782C2 - Засіб для зниження загального рівня холестерину в плазмі крові ссавця, спосіб зниження загального рівня холестерину в плазмі крові ссавця та поживний харчовий продукт - Google Patents

Засіб для зниження загального рівня холестерину в плазмі крові ссавця, спосіб зниження загального рівня холестерину в плазмі крові ссавця та поживний харчовий продукт

Info

Publication number
UA27782C2
UA27782C2 UA93004309A UA93004309A UA27782C2 UA 27782 C2 UA27782 C2 UA 27782C2 UA 93004309 A UA93004309 A UA 93004309A UA 93004309 A UA93004309 A UA 93004309A UA 27782 C2 UA27782 C2 UA 27782C2
Authority
UA
Ukraine
Prior art keywords
cholesterol
mammal
total level
blood plasm
blood
Prior art date
Application number
UA93004309A
Other languages
English (en)
Russian (ru)
Inventor
Даніель Д. ГЕЛЛЕХЕР
Даниэль Д. Геллехер
Крейг А. ХЕССЕЛ
Крэйг А. Хессел
Кунг-Дж ЛІ
Кунг-Дж Ли
Original Assignee
Регентс Оф Зе Юніверсіті Оф Мінесота
Регентс Оф Зе Юниверсити Оф Миннесота
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Регентс Оф Зе Юніверсіті Оф Мінесота, Регентс Оф Зе Юниверсити Оф Миннесота filed Critical Регентс Оф Зе Юніверсіті Оф Мінесота
Publication of UA27782C2 publication Critical patent/UA27782C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/24—Cellulose or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/804—Low calorie, low sodium or hypoallergic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Винахід являє собою терапевтичний спосіб зниження загального рівня холестерину в плазмі крові ссавців, у тому числі людини. Велика кількість речовин, ефективних у практиці цього винаходу, виробляються промислово або можуть бути легко одержані по звичайних методиках органічного синтезу. Ці матеріали нетоксичні в дозуваннях, що рекомендуються, як правило, без смаку і дуже малокалорійні.
UA93004309A 1991-03-08 1992-02-28 Засіб для зниження загального рівня холестерину в плазмі крові ссавця, спосіб зниження загального рівня холестерину в плазмі крові ссавця та поживний харчовий продукт UA27782C2 (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66639291A 1991-03-08 1991-03-08
US07/840,178 US5721221A (en) 1991-03-08 1992-02-24 Lowering blood cholesterol levels using water soluble cellulose ethers
PCT/US1992/001511 WO1992015313A1 (en) 1991-03-08 1992-02-28 Lowering blood cholesterol levels using cellulose ethers

Publications (1)

Publication Number Publication Date
UA27782C2 true UA27782C2 (uk) 2000-10-16

Family

ID=27099455

Family Applications (1)

Application Number Title Priority Date Filing Date
UA93004309A UA27782C2 (uk) 1991-03-08 1992-02-28 Засіб для зниження загального рівня холестерину в плазмі крові ссавця, спосіб зниження загального рівня холестерину в плазмі крові ссавця та поживний харчовий продукт

Country Status (21)

Country Link
US (2) US5721221A (uk)
EP (1) EP0503496B1 (uk)
JP (3) JP3651894B2 (uk)
KR (1) KR100216495B1 (uk)
AT (1) ATE117555T1 (uk)
AU (1) AU657301B2 (uk)
CA (1) CA2062412C (uk)
DE (1) DE69201255T2 (uk)
DK (1) DK0503496T3 (uk)
ES (1) ES2068623T3 (uk)
FI (1) FI933893A0 (uk)
GR (1) GR3015652T3 (uk)
HK (1) HK1010036A1 (uk)
HU (1) HUT65208A (uk)
IE (1) IE67435B1 (uk)
IL (1) IL101148A (uk)
MX (1) MX9201014A (uk)
NO (1) NO306284B1 (uk)
UA (1) UA27782C2 (uk)
WO (1) WO1992015313A1 (uk)
ZA (1) ZA921691B (uk)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281584A (en) * 1992-02-28 1994-01-25 The Dow Chemical Company Effect of particle-size distribution of cellulose ethers on palatability of compositions
US5932258A (en) * 1998-04-06 1999-08-03 The Iams Company Composition and process for improving glucose metabolism in companion animals
US6458378B1 (en) 1999-03-16 2002-10-01 The Iams Company Pet food composition for controlling postprandial glycemic response
US7001618B1 (en) 1999-07-09 2006-02-21 The Iams Company Nutritional composition for weight management
US6630159B2 (en) * 1999-02-23 2003-10-07 The Procter & Gamble Company Limiting weight gain of cats by feeding carbohydrate source that excludes rice
WO2003030916A1 (en) * 2001-10-12 2003-04-17 Regents Of The University Of Minnesota Medical and nutritional applications of highly refined cellulose
US6899892B2 (en) * 2001-12-19 2005-05-31 Regents Of The University Of Minnesota Methods to reduce body fat
US6835558B2 (en) * 2002-02-04 2004-12-28 General Mills, Inc. Beta-glucan compositions and process therefore
US20040109922A1 (en) * 2002-08-21 2004-06-10 Thai Huy Lam Fruit sponge
ITMI20050391A1 (it) * 2005-03-11 2006-09-12 Ph & T S P A Formulazioni a rilascio controllato di alfuzosin
TW200729300A (en) * 2005-11-30 2007-08-01 Nuflare Technology Inc Film-forming method and film-forming equipment
US20070123490A1 (en) * 2005-11-30 2007-05-31 Yokoyama Wallace H Preventing or reducing oxidative stress or oxidative cell injury
CA2666936A1 (en) * 2006-10-20 2008-05-02 Dow Global Technologies Inc. Method of preventing or treating metabolic syndrome
US20110071107A1 (en) * 2006-10-20 2011-03-24 Stephanie K Lynch Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome
JP4979735B2 (ja) * 2009-05-19 2012-07-18 信越化学工業株式会社 油ちょう用ドウ組成物及び油ちょうされたドウ組成物の製造方法
JP2011087490A (ja) * 2009-10-21 2011-05-06 Shin-Etsu Chemical Co Ltd 食肉添加剤、ピックル液及び食肉加工品
JP2012217413A (ja) * 2011-04-12 2012-11-12 Shin-Etsu Chemical Co Ltd 起泡性乳組成物
WO2013059065A1 (en) * 2011-10-19 2013-04-25 Dow Global Technologies Llc Methods and compositions for inducing satiety
WO2013066137A1 (ko) * 2011-11-04 2013-05-10 삼성정밀화학 주식회사 저지방 마요네즈 조성물 및 이의 제조방법
KR102160903B1 (ko) * 2012-07-17 2020-10-05 다우 글로벌 테크놀로지스 엘엘씨 고도로 치환된 하이드록시알킬 메틸셀룰로즈를 포함하는 고체 분산물
ITFI20120268A1 (it) * 2012-12-03 2014-06-04 Diopeite Consulting Ltd Composizioni farmaceutiche per il trattamento dell'obesita'
US11547125B2 (en) 2015-02-13 2023-01-10 Mars, Incorporated Pet food feeding system

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2701782A (en) * 1951-05-11 1955-02-08 Upjohn Co Method of making and aqueous suspension of methyl cellulose
US2802741A (en) * 1953-09-21 1957-08-13 Dow Chemical Co Cake mixes containing water-soluble cellulose ethers
US2883327A (en) * 1954-05-03 1959-04-21 Upjohn Co Reducing the gelation of methylcellulose by the addition of a neutral, water-soluble, amino carboxylic acid and product thereof
US2831852A (en) * 1954-05-27 1958-04-22 Dow Chemical Co Water-soluble thermoplastic cellulose ethers
US3308020A (en) * 1961-09-22 1967-03-07 Merck & Co Inc Compositions and method for binding bile acids in vivo including hypocholesteremics
US3383281A (en) * 1961-09-22 1968-05-14 Merck & Co Inc Method for binding bile acids in vivo
US3342805A (en) * 1964-05-27 1967-09-19 Dow Chemical Co Process for the manufacture of cellulose ethers
US3499960A (en) * 1965-01-25 1970-03-10 Merck & Co Inc Palatable coated particles of an anion exchange resin
US3388082A (en) * 1965-11-01 1968-06-11 Dow Chemical Co Novel hydroxypropyl methyl cellulose ethers, a process for preparing the same, and compositions utilizing such ethers
US3627872A (en) * 1968-04-08 1971-12-14 Upjohn Co Oral treatment of hyper-cholesteremia in mammals and birds with ether-type anion exchangers of polysaccharides
US3721735A (en) * 1970-07-15 1973-03-20 C Thiffault Compositions for and method of lowering cholesterol levels
US3709876A (en) * 1972-04-10 1973-01-09 Dow Chemical Co Water soluble hydroxyethyl methyl cellulose ether thickener for latex paint
GB1506217A (en) * 1975-08-26 1978-04-05 Taiho Pharmaceutical Co Ltd Oral antilipemic composition
US4005195A (en) * 1976-02-12 1977-01-25 The Procter & Gamble Company Compositions for treating hypercholesterolemia
US4109018A (en) * 1976-05-27 1978-08-22 Thompson Jerome B Low calorie diet bread
US4265879A (en) * 1977-09-13 1981-05-05 Monsanto Company Method for controlling blood triglycerides
US4284649A (en) * 1977-11-22 1981-08-18 Wiczer Sol B Thickened gelatinous edible alcoholic medicated carrier
US4175124A (en) * 1977-12-30 1979-11-20 The Quaker Oats Company Method of treating hypercholesterolemia
EP0005977A3 (en) * 1978-05-30 1980-01-09 The Speywood Laboratory Ltd. Bread containing gum and its manufacture
GB2021948A (en) * 1978-05-30 1979-12-12 Speywood Lab Ltd Water miscible gum composition and its preparation and use
DK221879A (da) * 1978-10-02 1980-04-03 Sepywood Lab Ltd Gummi dets fremstilling og anvendelse
US4251519A (en) * 1979-07-30 1981-02-17 Anheuser-Busch, Incorporated Process for the prevention and reduction of elevated blood cholesterol and triglycerides levels
US4362711A (en) * 1980-07-11 1982-12-07 Evreka Inc. Blood cholesterol level reducing agent and method
US4326523A (en) * 1980-08-25 1982-04-27 International Minerals & Chemical Corp. Method of supplying micronutrients to animals
US4432968A (en) * 1980-10-20 1984-02-21 The Dow Chemical Company Weight control with fat imbibing polymers
US4444761A (en) * 1981-05-04 1984-04-24 Syntex (U.S.A.) Inc. Cellulose/carboxymethyl cellulose mixtures useful for controlling fecal output, and methods employing them
JPS58135805A (ja) * 1982-02-08 1983-08-12 Teijin Ltd アレルギー性鼻炎治療又は予防剤
US4461782A (en) * 1982-02-16 1984-07-24 The Procter & Gamble Company Low calorie baked products
US4451490A (en) * 1982-03-08 1984-05-29 General Foods Corporation High quality, reduced-calorie cake containing cellulose and process thereof
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4410693A (en) * 1982-08-12 1983-10-18 The Dow Chemical Company Process for preparing cellulose derivatives
US4923981A (en) * 1982-09-03 1990-05-08 Sbp, Inc. Use of parenchymal cell cellulose to improve comestibles
US4520017A (en) * 1983-02-04 1985-05-28 Tunc Deger C Method of reducing nutrient absorption
NZ207125A (en) * 1983-02-17 1986-07-11 Merrell Pharma Inc Bulk laxative composition containing water-soluble cellulose ether
JPS59155309A (ja) * 1983-02-22 1984-09-04 Teijin Ltd 活性型ビタミンｄ↓３類組成物
US4477657A (en) * 1983-07-08 1984-10-16 The Dow Chemical Company Process for preparing hydroxyalkylcellulose ethers
JPS60142911A (ja) * 1983-12-29 1985-07-29 Nippon Soda Co Ltd 口腔内組成物
US4626287A (en) * 1985-01-29 1986-12-02 Merrell Dow Pharmaceuticals Inc. Process for preparing sucrose encrusted methylcellulose particles for use in bulk laxative compositions
US4614545A (en) * 1985-08-15 1986-09-30 The Dow Chemical Company Hydroxypropyl methyl cellulose thickening agents for organic liquids
SE458576B (sv) * 1985-06-20 1989-04-17 Lejus Medical Ab Foerfarande foer framstaellning av en guar-gum produkt
US4734285A (en) * 1985-10-28 1988-03-29 The Dow Chemical Company Sustained release compositions
US4704285A (en) * 1985-11-18 1987-11-03 The Dow Chemical Company Sustained release compositions comprising hydroxypropyl cellulose ethers
JPS62122671A (ja) * 1985-11-23 1987-06-03 千寿製薬株式会社 眼内手術用高粘性液の製造法
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
US4820813A (en) * 1986-05-01 1989-04-11 The Dow Chemical Company Grinding process for high viscosity cellulose ethers
JPH0657245B2 (ja) * 1986-05-14 1994-08-03 ト−メ−産業株式会社 眼科手術用粘弾性溶液
US4883788A (en) * 1986-06-06 1989-11-28 Hauser-Kuhrts, Inc. Method and composition for reducing serum cholesterol
JPS63112959A (ja) * 1986-06-30 1988-05-18 Terumo Corp 炊飯した低カロリー穀物の製造方法
GB8616669D0 (en) * 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
US4789664A (en) * 1986-12-19 1988-12-06 The Procter & Gamble Company Food compositions with superior blood cholesterol lowering properties
CA1313135C (en) * 1987-02-09 1993-01-26 The Dow Chemical Company Cholestyramine composition and process for its preparation
US4849222A (en) * 1987-03-24 1989-07-18 The Procter & Gamble Company Mixtures for treating hypercholesterolemia
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US4950140A (en) * 1987-09-14 1990-08-21 The Procter & Gamble Company Cookies containing psyllium
EP0323666B1 (en) * 1987-12-29 1992-03-25 The Procter & Gamble Company Mixed compositions for treating hypercholesterolemia
US4959466A (en) * 1988-01-25 1990-09-25 Arco Chemical Technology, Inc. Partially esterified polysaccharide (PEP) fat substitutes
US4846889A (en) * 1988-02-02 1989-07-11 The Dow Chemical Company Polymeric blend useful in thin-bed mortar compositions comprising a water-soluble cellulose ether and a water-insoluble, but water-dispersible polymer
US4900573A (en) * 1988-06-17 1990-02-13 The Dow Chemical Company Method of inhibiting oil adsorption in coated fried foods using hydroxypropyl methyl cellulose
CA1331535C (en) * 1988-10-03 1994-08-23 Paul Dale Leis Jr. Psyllium-containing products
FI895708A7 (fi) * 1989-02-10 1990-08-11 Alko Ab Oy Vesiliukoinen hajoamistuote
NZ232432A (en) * 1989-02-10 1991-09-25 Alko Ltd Food compositions in which (some of) a high-energy ingredient is replaced by a degraded cellulose derivative with average molecular weight between 500 and 100000
US5268181A (en) * 1989-04-13 1993-12-07 Upsher-Smith Laboratories, Inc. Method of using niacin to control nocturnal cholesterol synthesis
US4996063A (en) * 1989-06-30 1991-02-26 The United States Of America, As Represented By The Secretary Of Agriculture Method for making a soluble dietary fiber composition from oats
US5219599A (en) * 1990-02-23 1993-06-15 Lipidyne Corporation Artificial adipose
US5213829A (en) * 1990-02-23 1993-05-25 Lipidyne Corporation Meat products containing artificial edible adipose and methods of making
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
HU222487B1 (hu) * 1991-03-01 2003-07-28 The Dow Chemical Co. Eljárás vízoldékony, nagy viszkozitású, szérum lipidszint csökkenő vagy vér glükozszint emelkedését enyhítő cellulóz-éter gyógyszerkészítmények előállítására
US5281584A (en) * 1992-02-28 1994-01-25 The Dow Chemical Company Effect of particle-size distribution of cellulose ethers on palatability of compositions

Also Published As

Publication number Publication date
CA2062412C (en) 2002-10-15
ES2068623T3 (es) 1995-04-16
GR3015652T3 (en) 1995-07-31
JP3651894B2 (ja) 2005-05-25
KR100216495B1 (ko) 1999-08-16
JP2007217424A (ja) 2007-08-30
HUT65208A (en) 1994-05-02
EP0503496B1 (en) 1995-01-25
DK0503496T3 (da) 1995-04-10
CA2062412A1 (en) 1992-09-09
NO933104L (no) 1993-08-31
EP0503496A1 (en) 1992-09-16
JP4116861B2 (ja) 2008-07-09
FI933893L (fi) 1993-09-06
AU1149392A (en) 1992-09-10
AU657301B2 (en) 1995-03-09
WO1992015313A1 (en) 1992-09-17
US5585366A (en) 1996-12-17
ZA921691B (en) 1993-11-17
US5721221A (en) 1998-02-24
FI933893A7 (fi) 1993-09-06
ATE117555T1 (de) 1995-02-15
IE67435B1 (en) 1996-04-03
DE69201255T2 (de) 1995-07-20
MX9201014A (es) 1992-09-01
FI933893A0 (fi) 1993-09-06
HU9302531D0 (en) 1993-12-28
NO933104D0 (no) 1993-08-31
HK1010036A1 (en) 1999-06-11
JPH06505488A (ja) 1994-06-23
NO306284B1 (no) 1999-10-18
DE69201255D1 (de) 1995-03-09
IL101148A0 (en) 1992-11-15
IL101148A (en) 2001-10-31
JP2003155243A (ja) 2003-05-27
IE920730A1 (en) 1992-09-09

Similar Documents

Publication Publication Date Title
ES2131504T3 (es) Trombina humana purificada viricamente segura.
DE69435284D1 (de) Behandlung neuromuskulärer Erkrankungen und Zustände mit verschiedenem Botulin-Serotyp
HU9201700D0 (en) Oral preparations for treating internal inflammations and process for its production
ES2104062T3 (es) Productos untable de frutas con un contenido reducido en calorias.
FI840615A0 (fi) Foer framstaellning av laekemedelsadsorbat laempligt magnesiumtrisilikat
AP9100310A0 (en) Tnf inhibitors
ATE235251T1 (de) Verwendung von amlodipin, eines seiner salze oder felodipin in kombination mit einem ace-hemmer zur herstellung eines arzneimittels zur behandlung von nicht ischämischer kongestiver herzinsuffizienz
DE3882135D1 (de) Verwendung von melatonin oder seine derivate zur herstellung von arzneimitteln, die gegen alterskrankheiten wirksam sind.
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
DE69130063D1 (de) Antivirales arzneimittel enthaltend prostratin
EP0325129A3 (en) Disubstituted pyridines
RU95115286A (ru) Способ лечения рака легкого
AR004722A1 (es) Procedimiento y aparato para preparar cereales hidrolizados con frutas o miel anadidas y los productos asi obtenidos.
JPS57112331A (en) Medical composition of ganoderma lucidum component
ES2129654T3 (es) Dosificacion directa del colesterol.
RU93000004A (ru) Вещество для лечения подкожной фибрасаркомы и способ его получения
NO874008D0 (no) Fremgangsmaate for behandling av fisk ved oppdeling, og anordning forutfoerelse av fremgangsmaaten.
Smith et al. Peripheral neuropathy after amitriptyline
KR940013382A (ko) 양념불고기를 이용한 냉동돈까스의 제조방법
JPS6443166A (en) Seasoning
RU94002713A (ru) Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда)
Lawson et al. The optimum intake of vitamin C: history and controversy
宋宝珠 et al. SHORT-TERM EFFECT IN 135 CASES OF ENURESIS TREATED BY WRIST-ANKLE NEEDLING
Escudier et al. Intensive statin tiierapy demonstrated to be safe and effective in tiie eideriy
MA19098A1 (fr) Procede de preparation de derives de bis -piperazino-androstane et nouveaux produits ainsi obtenus , notamment a action de relaxation des muscles .